GloriousMed Technology Co.

BiotechnologySeries BBeijing, Chinagloriagene.cn

Latest round

Series B

Last raised

Nov 2021

Total raised

$27M

Investors

3

About GloriousMed Technology Co.

, Ltd. is a comprehensive big data medical platform specializing in the integration of tumor precision immunodiagnosis and treatment, which integrates production, education and research. The company build a industry-university-research service system to provide a complete set of solutions for the integration of tumor precision immunodiagnosis and treatment, including the Chinese Academy of Sciences, Chinese Academy of Medical Sciences. The company has a testing institution with 2,000 square meters that the scope of testing and diagnosis projects carried out includes medical laboratory, clinical body fluids, hematology, clinical chemistry, clinical immunization, serology, cell and molecular biology, etc. In 2017, it proposes the "Tumor Immunity Ark Project", which combines clinical phenotype data and drug efficacy follow-up data, explore the evaluation standards and evaluation system of tumor immunodiagnosis and treatment, and finally realize clinical transformation. The company provides integrated solution for precision diagnosis and treatment of tumors, relying on genetic testing technology and multi-dimensional and multi-omics testing platform. Specific solution includes urinary tumors, breast cancer, lung cancer, other solid tumors, and precision immunity. The company plans to build an academic communication platform for clinical experts, pharmaceutical companies, and basic research experts. As well as it will promote the application and registration of standard test kits for products tested in clinical research and application.

Who invested in GloriousMed Technology Co.

3 investors across 2 rounds

See all investors in GloriousMed Technology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 8, 2021

    Amount

    $16M

    Investors

    Locked

  2. Series A

    Aug 1, 2018

    Amount

    $11M

    Investors

    Locked

Questions about GloriousMed Technology Co.

Who invested in GloriousMed Technology Co.?

GloriousMed Technology Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GloriousMed Technology Co. raised?

GloriousMed Technology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did GloriousMed Technology Co. last raise money?

GloriousMed Technology Co.'s most recent round on record is a Series B, in Nov 2021.

What does GloriousMed Technology Co. do?

GloriousMed Technology Co. is a biotechnology company.

Where is GloriousMed Technology Co. headquartered?

GloriousMed Technology Co. is headquartered in Beijing, China.

Which VCs invest in companies like GloriousMed Technology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at GloriousMed Technology Co.'s stage. Their profiles are linked below.

Raising like GloriousMed Technology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.